Lidocaine Infusion Versus Magnesium Infusion in Decreasing Fentanyl Requirements in Endoscopic Sinus Surgeries

Launched by CAIRO UNIVERSITY · May 3, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how effective two different treatments—lidocaine and magnesium sulfate—are in reducing the amount of fentanyl needed for pain relief during and after a specific type of surgery called functional endoscopic sinus surgery. This surgery is often performed to treat chronic sinus problems. The goal is to find out which infusion works better to manage pain, helping patients recover more comfortably after their procedure.

To participate in this study, you need to be between the ages of 21 and 60, and be scheduled for this type of surgery under general anesthesia. You also need to be in good health, as defined by certain medical standards. If you have certain health conditions, such as kidney disease or allergies to lidocaine or magnesium, you may not be eligible. If you choose to participate, you can expect to receive one of the two treatments during your surgery, and researchers will closely monitor your pain levels and recovery. Overall, this trial aims to improve pain management for patients undergoing sinus surgery, making recovery easier and more effective.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age from 21 to 60 years.
• • Both genders.
• • American society of Anesthesiologist (ASA) physical status I-II
• • Scheduled for functional endoscopic sinus surgery under general anesthesia.
• Exclusion Criteria:
• • Patients with prolonged QT interval.
• • Patients with renal disease.
• • Patients with a history of allergy to lidocaine or magnesium sulfate.
• • American Society of Anesthesiologists class higher than II.
• • Patient refusal